Peter Fenici

Peter Fenici Email and Phone Number

Head of Medical Innovation at AZ. Partner at HT180 Healthcare Venture Building. R&D/BD at BACPIC. Contract Professor teaching at Catholic University School of Medicine.. @ AstraZeneca
Peter Fenici's Location
Italy, Italy
Peter Fenici's Contact Details

Peter Fenici personal email

n/a
About Peter Fenici

Medical doctor, specialist in internal medicine and emergency medicine, owns a PhD in clinical application of innovative integrated multimodal imaging solutions (including pioneering research in Magnetocardiography - MCG), and a Global Executive MBA with specific focus on entrepreneurship and innovation. Academically engaged in teaching at the Catholic University School of Medicine and Surgery, as contract professor, at the PharmaTech Academy held by the University of Naples Federico II, and as invited speaker at different University's courses, conferences and educational events. Head of Medical Innovation at AstraZeneca, where he is dedicated in building new platforms for research and innovative solution in healthcare. He is engaged in the CaReMe Global Alliance, aimed at scaling integrated multidisciplinary care for patients living in the CVRM risk continuum, including chronic co-morbidities, applying RWE for quality of care monitoring and scouting innovative digital health technologies, remote monitoring devices and patient's management solutions. He is also a non-executive Partner at HealthTech180, acting as scientific and research advisor for start-ups and former Chairman of the Board at Hemostatics and at Exostatics. Life dedicated as a clinician/researcher/business leader to identify and implement effective, personalised and possibly scalable solutions to help people succeed in living a healthy live, addressing life-threatening conditions in the acute emergency settings as well as preventing epidemic-size diseases that share common pathways and removable behaviour-related risk factors. Passionate about the ongoing healthcare ecosystem revolution, keeping a scientific and research focus (both in industry and academia), understanding the role of distributed ledger/blockchain, home-Lab, wearable sensors, life-style and diet intervention as part of feasible and sustainable health self-management solutions. Strong supporter and user of AI-enhanced Point of Care Ultrasound envisioned for the democratisation of diseases' early diagnosis and management. Continuously mentoring and tutoring students from high school to university, but also more senior colleagues seeking for advice in their professional life. Fortunate husband and proud father, blessed by a wonderful large family and meaningful life.

Peter Fenici's Current Company Details
AstraZeneca

Astrazeneca

View
Head of Medical Innovation at AZ. Partner at HT180 Healthcare Venture Building. R&D/BD at BACPIC. Contract Professor teaching at Catholic University School of Medicine..
Peter Fenici Work Experience Details
  • Astrazeneca
    Head Of Medical Innovation
    Astrazeneca Oct 2021 - Present
    Cambridge, Cambridgeshire, Gb
    Responsible for bringing innovation across the AZ portfolio within projects aimed at transforming healthcare delivery, including "digital health" solutions; designing and implementing novel models to expand the efficacy and engagement in preclinical and clinical research, including also Public Private Partnerships, and exploring the evolution of a new level of a corporate entrepreneurial mindset.
  • Astrazeneca
    Head Of Innovation Cardiovascular Renal And Metabolism
    Astrazeneca Jun 2018 - Oct 2021
    Cambridge, Cambridgeshire, Gb
  • Astrazeneca
    Global Medical Affairs Sr Director Diabetes
    Astrazeneca Oct 2014 - Jun 2018
    Cambridge, Cambridgeshire, Gb
  • Astrazeneca
    European Medical Lead Diabetes
    Astrazeneca Feb 2014 - Oct 2014
    Cambridge, Cambridgeshire, Gb
    Currently responsible for the European region of the launch related medical activities of dapagliflozin + metformin FDC, to complement dapagliflozin monotherapy. Part of the workstreams for the saxagliptin-dapaglflozin FDC ongoing Ph 3 clinical program, as well as for the evaluation of clinical and preclinical ISR and Ph4. Both product are managed inside the “diabetes portfolio” (5 products) to ensure synergies and leverage the risk of internal cannibalization. In this respect, strong collaboration within the Global Medical Leads, Global and Regional HEOR and Market Access directors is in place, as well as with the Medical therapeutic Area Heads in country. Study Director of APLE-pY, the first NIR-RWE study designed and implemented to translate RCT clinical program results for a SGLT2i into real world evidence, with the aim to provide evidence for clinical, health economics and market access discussions.Responsible for the redesign of a new internal digital communication channel based on SharePoint aimed to ensure timely scientific news delivery inside the EMEA medical organization and a comprehensive and easily accessible repository of all the data available for the products as well as the short to long term medical plan strategy and deliverables.
  • Hemostatics
    Scientific & Research Senior Advisor
    Hemostatics Jan 2024 - Present
    Barcelona, Es
  • Hemostatics
    Chairman Of The Board
    Hemostatics Aug 2020 - Dec 2023
    Barcelona, Es
    Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions.Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases).Trauma Civilian & Military - Surgery - ICH - Gynecology - Rare Diseases - GI Bleeding
  • Healthtech180
    Partner
    Healthtech180 Sep 2021 - Present
    Barcelona, Catalonia, Es
    Driving Healthcare Innovation from Tech Scouting to Venture BuildingOur mission is to accompany innovative technologies from science bench to business success in areas of high unmet medical need. We are an established interdisciplinary team of experienced executives, consultants, doctors, investors and financial advisors who perform an in-depth due diligence process to advance the most promising life-changing technologies.Patents Scouting - Venture Building - Funding - M&A - Licensing – Scaling
  • Healthtech180
    Venture Partner
    Healthtech180 Aug 2020 - Sep 2021
    Barcelona, Catalonia, Es
  • Healthtech180
    Senior Advisor
    Healthtech180 Sep 2019 - Aug 2020
    Barcelona, Catalonia, Es
  • Università Cattolica Del Sacro Cuore
    Contract Professor
    Università Cattolica Del Sacro Cuore Jul 2021 - Present
    It
    Teaching Healthcare Delivery Trasformation, Medical Innovation, Digital Health, Artificial Intelligence, Interdisciplinary Integrated Models of care, Preventive Medicine, role of Real-World Evidence, Pharmaceutical R&D from bench to bedside, Entrepreneurship, within the Course of Endocrine and Metabolic Diseases at the School of Medicine and Surgery
  • Biomagnetism And Clinical Physiology International Center (Bacpic)
    Research & Business Development Specialist
    Biomagnetism And Clinical Physiology International Center (Bacpic) Mar 2021 - Present
    Responsible for the R&D and BD strategy at BACPIC in the field of the clinical and research application of Magnetocardiography (MCG) aimed at ealier and more accurate diagnosis of acute and chronic cardiac diseases within a vision of preventive medicine. BACPIC is an established leading international research center, and recently an university spin-off, with 30+ years of R&D experience in cardiology, tech development (patents) and MCG.
  • Royal College Of Physicians Of Edinburgh
    Invited Fellow Of The Royal College Of Physician Of Edinburg (Rcpe)
    Royal College Of Physicians Of Edinburgh Oct 2015 - Present
    Edinburgh, Lothian, Gb
  • Exostatics Pharmaceuticals
    Chairman Of The Board
    Exostatics Pharmaceuticals Oct 2021 - Oct 2023
    Barcelona, Es
    Expanding the Power of Exosomes for Diagnostic and Therapeutic ApplicationsExostatics developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, Exostatics provides a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions.Exosomes - At-home Diagnostics - Therapeutics - Isolation kits - Blood Purifying - Diagnostic Kits
  • Surrey Business School, University Of Surrey
    Guest Lecturer
    Surrey Business School, University Of Surrey Jun 2019 - Jun 2019
    Guildford, Surrey, Gb
    Lecturing at a satellite symposium by the MBA Programmes, Surrey Business School, about the innovation in the healthcare ecosystem and the role of pharmaceutical industry
  • Università Degli Studi Di Napoli Federico Ii
    Guest Lecturer
    Università Degli Studi Di Napoli Federico Ii May 2018 - May 2018
    Teaching at a satellite symposium about the role of RWE methodology and data in diabetes, cardiovascular and renal outcomes at the Course of specialization in endocrinology school of medicine and surgery
  • Università Cattolica Del Sacro Cuore
    Contract Professor
    Università Cattolica Del Sacro Cuore Feb 2018 - Feb 2018
    It
    Vertical Seminars at the School of Medicine and Surgery about Innovation in healthcare and the role of RWE
  • Bristol-Myers Squibb
    European Senior Medical Lead Forxiga
    Bristol-Myers Squibb May 2013 - Feb 2014
    Lawrence Township, Nj, Us
    Leading launch medical strategy and activities in European countries, as liason between Global and Countries. Design and implementation of RWE - NIR studies and Ph4 program for data gap filling in Europe according to access requirements. Insight provider and active member of Global strategic data review team. Collaboration in different data generation projects and NMA in partnership with Health Economics colleagues. Internal training and regular scientific updates cross functional. Strong collaboration with Commercial and Market Access teams.
  • Bristol-Myers Squibb
    Associate European Medical Lead
    Bristol-Myers Squibb May 2012 - May 2013
    Lawrence Township, Nj, Us
  • Bristol-Myers Squibb
    Cardiovascular And Metabolic Diseases Area Head
    Bristol-Myers Squibb 2005 - May 2012
    Lawrence Township, Nj, Us
    Leading the cardiovascular, metabolism, pain and ultrasound contrast media therapeutic areas.
  • Università Cattolica Del Sacro Cuore
    Emergency Physician
    Università Cattolica Del Sacro Cuore 2001 - 2005
    It
  • Università Cattolica Del Sacro Cuore
    Research Fellowship In Cardiology, Clinical Physiology And Biomagnetism
    Università Cattolica Del Sacro Cuore 1991 - 2005
    It
  • Università Cattolica Del Sacro Cuore
    Residency On Internal Medicine & Emergency Medicine
    Università Cattolica Del Sacro Cuore 1997 - 2002
    It

Peter Fenici Skills

Cardiology Clinical Trials Pharmaceutical Industry Diabetes Clinical Research Clinical Development Medicine Medical Affairs Market Access Management Medical Education Healthcare Internal Medicine Health Economics Gcp Biotechnology Pharmaceutical Sales Oncology Medical Writing Medical Research Life Sciences People Management Drug Development Pharmacovigilance Cancer Endocrinology Neurology Pharmacology Cro Ich Gcp Infectious Diseases Immunology Multitasker Lifesciences Epidemiology Psychiatry Emergency Medicine Hematology

Peter Fenici Education Details

  • Learn Behavior Design With Bj Fogg, Phd
    Learn Behavior Design With Bj Fogg, Phd
    Behavioral Sciences
  • Squared Online
    Squared Online
  • Sda Bocconi
    Sda Bocconi
    General
  • Università Cattolica Del Sacro Cuore
    Università Cattolica Del Sacro Cuore
    Clinical Applications Of Magnetocardiograhy
  • Università Cattolica Del Sacro Cuore
    Università Cattolica Del Sacro Cuore
    Specialization In Internal Medicine And Emergency Medicine
  • Sapienza Università Di Roma
    Sapienza Università Di Roma
    Medical School

Frequently Asked Questions about Peter Fenici

What company does Peter Fenici work for?

Peter Fenici works for Astrazeneca

What is Peter Fenici's role at the current company?

Peter Fenici's current role is Head of Medical Innovation at AZ. Partner at HT180 Healthcare Venture Building. R&D/BD at BACPIC. Contract Professor teaching at Catholic University School of Medicine...

What is Peter Fenici's email address?

Peter Fenici's email address is pe****@****bms.com

What is Peter Fenici's direct phone number?

Peter Fenici's direct phone number is +3934897*****

What schools did Peter Fenici attend?

Peter Fenici attended Learn Behavior Design With Bj Fogg, Phd, Squared Online, Sda Bocconi, Università Cattolica Del Sacro Cuore, Università Cattolica Del Sacro Cuore, Sapienza Università Di Roma.

What skills is Peter Fenici known for?

Peter Fenici has skills like Cardiology, Clinical Trials, Pharmaceutical Industry, Diabetes, Clinical Research, Clinical Development, Medicine, Medical Affairs, Market Access, Management, Medical Education, Healthcare.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.